GigaMune was founded as a spin-out from GigaGen in 2017. We focus on T cell therapeutics for solid tumors.
Location: United States, California, South San Francisco
Employees: 11-50
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Bioverge | ventures.b... |
Mentions in press and media 1
| Date | Title | Description |
| 01.05.2019 | GigaMune Secures Angel Financing | GigaMune, a South San Francisco, CA-based developer of anti-tumor T Cell receptor programs, secured a strategic convertible debt financing of undisclosed amount. Investors included several technology and biotech CEOs. The company will use t... |